9

LMWH – New mechanisms of action

Année:
2009
Langue:
english
Fichier:
PDF, 79 KB
english, 2009
21

Development of idraparinux and idrabiotaparinux for anticoagulant therapy

Année:
2009
Langue:
english
Fichier:
PDF, 122 KB
english, 2009
22

IDIOSYNCRATIC RISK, AGGREGATE RISK, AND THE WELFARE EFFECTS OF SOCIAL SECURITY

Année:
2018
Langue:
english
Fichier:
PDF, 543 KB
english, 2018
24

Review of pharmacodynamics, pharmacokinetics, and therapeutic properites of sulodexide

Année:
1998
Langue:
english
Fichier:
PDF, 215 KB
english, 1998
28

Purity of glycosaminoglycan-related compounds using capillary electrophoresis

Année:
1996
Langue:
english
Fichier:
PDF, 486 KB
english, 1996
30

Purification of the monoclonal heparin antibody H-1.18

Année:
1996
Langue:
english
Fichier:
PDF, 463 KB
english, 1996
34

Characterization of heparins by high-performance size exclusion liquid chromatography

Année:
1983
Langue:
english
Fichier:
PDF, 396 KB
english, 1983
37

Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG

Année:
1999
Langue:
english
Fichier:
PDF, 74 KB
english, 1999
44

Book reviews

Année:
1985
Langue:
english
Fichier:
PDF, 334 KB
english, 1985
45

Hypercoagulability after immunotherapy with corynebacterium parvum in man

Année:
1982
Langue:
english
Fichier:
PDF, 348 KB
english, 1982
50

Urokinase therapy of subclavian-axillary vein thrombosis

Année:
1981
Langue:
english
Fichier:
PDF, 1.37 MB
english, 1981